EUVIMEDEUVIMED entdecken
Crossref

Analysis of Departures from Linearity in the Dose Response for Japanese Atomic Bomb Survivor Solid Cancer Mortality and Cancer Incidence Data and Assessment of Low-Dose Extrapolation Factors

Mark P Little, Nobuyuki Hamada, Harry M Cullings

Radiation Research · 2025

DOI: 10.1667/rade-24-00202.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Research, 2025. Verfasst von Mark P Little und 2 weiteren Autor:innen. Beteiligte Einrichtung: Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20892-9778. Hauptthemen laut MEDLINE: Neoplasms, Radiation-Induced, Atomic Bomb Survivors, Nuclear Weapons, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: NCI NIH HHS, US Department of Energy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although leukemia in the Japanese atomic bomb survivor data has long exhibited upward curvature, until recently this appeared not to be the case for solid cancer. It has been suggested that the recently observed upward curvature in the dose response for the Japanese atomic bomb survivor solid cancer mortality data may be accounted for by flattening of the dose response in the moderate dose range (0.3–0.7 Gy). To investigate this, the latest version available of the solid cancer mortality and incidence datasets (with follow-up over the years 1950–2003 and 1958–2009 respectively) for the Life Span Study cohort of atomic bomb survivors was used to assess possible departures from linearity in the moderate dose range. Linear-spline models were fitted, also up to 6th order polynomial models in dose (higher order polynomials tended not to converge). The organ dose used for all solid cancers was weighted dose to the colon. There are modest indications of departures from linearity for the mortality data, whether using polynomial or linear-spline models. Use of the Akaike information criterion (AIC) suggests that the optimal model for the mortality data is given by a 5th order polynomial in dose. There is borderline significant (P = 0.071) indication of improvement provided by a linear-spline model in the mortality data. The low-dose extrapolation factor (LDEF), which measures the degree of overestimation of low-dose linear slope by the linear slope fitted over some specified dose range, is generally between 1.1–2.0 depending on the dose range, with upper confidence limits that sometimes exceed 10; although LDEF < 1 for the lowest dose range ( 0.2) of improvement provided by linear-spline models. Nevertheless, use of AIC suggests that the optimal model for the incidence data is given by a 3rd order polynomial. LDEF evaluated over various dose ranges is generally between 1.2–1.4 with upper confidence limits that generally exceed 1.6; although LDEF < 1 for the lowest dose range (2 Gy. The linear-quadratic model is very widely used for modeling of dose response, and has been widely used in radiotherapy oncology applications as part of treatment planning. There is a theoretical basis for this model, based on the two-target model, although the data used to validate this has been mainly in vitro; there may be more complicated interactions than are implied by a two-target model, but the contributions made by these, which would contribute to higher order (than quadratic) powers of dose, may not be very pronounced over moderate ranges of dose.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Radiation-InducedAtomic Bomb SurvivorsNuclear WeaponsNeoplasmsHumansJapanIncidenceMaleDose-Response Relationship, RadiationFemaleMiddle AgedAdultAgedEast Asian People

Autor:innen und Institutionen

  • Radiation Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20892-9778.
  • Faculty of Health, Science and Technology, Oxford Brookes University, Headington Campus, Oxford, OX3 0BP, United Kingdom.
  • Biology and Environmental Chemistry Division, Sustainable System Research Laboratory, Central Research Institute of Electric Power Industry (CRIEPI), 1646 Abiko, Chiba 270-1194, Japan.
  • Chief (retired), Department of Statistics, Radiation Research Effects Foundation, Hiroshima, Japan.

Förderung

  • NCI NIH HHS
  • US Department of Energy

Zitieren

APA

Little, M. P., Hamada, N., & Cullings, H. M. (2025). Analysis of Departures from Linearity in the Dose Response for Japanese Atomic Bomb Survivor Solid Cancer Mortality and Cancer Incidence Data and Assessment of Low-Dose Extrapolation Factors. Radiation Research. https://doi.org/10.1667/rade-24-00202.1

Vancouver

Little MP, Hamada N, Cullings HM. Analysis of Departures from Linearity in the Dose Response for Japanese Atomic Bomb Survivor Solid Cancer Mortality and Cancer Incidence Data and Assessment of Low-Dose Extrapolation Factors. Radiation Research. 2025. doi:10.1667/rade-24-00202.1

BibTeX
@article{Little2025,
  author = {Little, Mark P and Hamada, Nobuyuki and Cullings, Harry M},
  title = {Analysis of Departures from Linearity in the Dose Response for Japanese Atomic Bomb Survivor Solid Cancer Mortality and Cancer Incidence Data and Assessment of Low-Dose Extrapolation Factors},
  journal = {Radiation Research},
  year = {2025},
  doi = {10.1667/rade-24-00202.1}
}
Kostenlos starten →